CD8 T-cell responses are critical for protection against intracellular pathogens and tumors. The induction and properties of these responses are governed by a series of integrated processes that rely heavily on cell-cell interactions. Intercellular adhesion molecule (ICAM)-1 functions to enhance the strength of antigenic stimulation, extend the duration of contact with antigen-presenting cells, and augment cytokine signals, which are all factors that influence peripheral CD8 T-cell differentiation. Although previous studies suggest that ICAM-1 is essential for establishing memory T-cell populations following peptide immunization, the roles of ICAM-1 in antiviral cellular immunity are less well understood. Here we show that, following a prototypic acute viral infection, the formation and maintenance of memory-phenotype CD127 hi , KLRG-1 lo CD8 T cells does not require ICAM-1. Nevertheless, ICAM-1 expression on nonlymphocytes dictates the phenotypic and functional attributes of the antiviral CD8 T-cell populations that develop and promotes the gradual attrition of residual effector-like CD127 lo , KLRG-1 hi CD8 T cells during the memory phase of the response. Although memory T cells do emerge and are maintained if ICAM-1 expression is abolished, the secondary proliferative capacity of these T cells is severely curtailed. Collectively, these studies reveal potential dual roles for ICAM-1 in both promoting the decay of effector responses and programming the sensitivity of memory CD8 T cells to secondary stimuli.
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immunological memory | recall responses T he initial priming of naïve CD8 T cells, and the subsequent activation of effector and memory T cells, critically depends upon their ability to interrogate and respond to the arrays of MHC class I molecules present on the surface of the target cell. This cellular intimacy, coupled with the detection of other triggers, shapes the fate decisions of the responding T cells. Among the early commands that T cells receive, the strength of antigenic stimulation, the duration of contact with antigen-presenting cells (APCs), and cytokine signals have been proposed to instruct their subsequent development (1, 2) . All these events are influenced by interactions mediated by intercellular adhesion molecule-1 (ICAM-1), (CD54) and its primary ligand, lymphocyte function-associated antigen (LFA)-1. Interactions governed by ICAM-1 can influence T-cell differentiation by promoting long duration contacts with APCs (3) and by facilitating asymmetric cell division (4) . Expression of ICAM-1 by the APCs also lowers the concentration of antigen required to activate a naïve T cell (5) , thereby enhancing the strength of antigenic stimulation, and engagement of LFA-1 by ICAM-1 has been proposed to have a costimulatory role (6, 7) . As the responding cells swarm, LFA-1 and ICAM-1 expressed upon T cells mediates T-cell-T-cell interactions and facilitates the directional secretion of IL-2 from one responding cell to another (8, 9) . ICAM-1-LFA-1 interactions have also been proposed to enhance IL-2 production by CD8 T cells, particularly during the early stages of the response (6) . These cytokine signals likely further cement the activation and differentiation of the responding T cells (10, 11) . Moreover, the priming of T cells to soluble peptide or protein antigens appears critically dependent upon ICAM-1, because after initial expansion both CD4 and CD8 T cells are not maintained in ICAM-1 deficient animals (3, 12) .
Although ICAM-1 plays a prominent role in multiple events that influence CD8 T-cell differentiation, the requirements for ICAM-1-mediated interactions in the development of CD8 T-cell memory to infection are not well studied. Several previous studies have harnessed ICAM-1-deficient mice with targeted deletions in exons 4 and 5, in which soluble or membrane-bound splice variants, respectively, may still be expressed (13) (14) (15) , thus potentially complicating their interpretation. In the current report, we have used ICAM-1 −/− (Icam1 tm1A1b ) mice, in which the entire coding region of the ICAM1 gene has been deleted (16, 17) , as well as experimental systems in which ICAM-1 expression is restricted to specific cell types. Rather than a mandatory role for ICAM-1 in the development of CD8 T-cell memory, as suggested by peptide priming studies (3), we detect equivalent or enhanced generation and maintenance of memory-phenotype (CD127 hi , KLRG-1 lo ) CD8 T cells following acute lymphocytic choriomeningitis virus (LCMV) infection of ICAM-1 −/− mice. Nevertheless, the expression of ICAM-1 on nonlymphocytes appears to be required for the attrition of "effector-like" CD127 lo , KLRG-1 hi virus-specific CD8 T cells, which usually occurs as immunological memory, is established. Surprisingly, the secondary proliferative responses of virus-specific CD8 T cells primed in the absence of ICAM-1 are severely curtailed. Thus, the adhesion molecule ICAM-1 plays a role in the quantitative and qualitative tuning of the memory CD8 T-cell responses.
Results

ICAM-1-Dependent Maturation of Memory CD8 T-Cell Responses.
Because ICAM-1 was reported to be necessary for the development of memory T-cell responses to soluble peptide antigens (3), we initiated studies to investigate whether ICAM-1 regulates CD8 T-cell responses following acute infection with the Armstrong (Arm) strain of LCMV. MHC tetramer staining ( Fig. 1 A and B) , as well as intracellular cytokine staining for IFN-γ ( Fig. 1 C, D , and G) and IL-2 (Fig. 1 E-G) , revealed that viral GP33-and NP396-specific CD8 T-cell responses were elicited in both C57BL/6 (ICAM-1
mice elevated numbers of virus-specific CD8 T cells were preserved beyond day 25 following infection. This finding was most apparent by MHC-tetramer staining and enumeration of IFN-γ-producing CD8 T cells, whereas the numbers of IL-2-producing cells exhibited a less significant elevation. Thus, the generation and maintenance of virus-specific CD8 T cells is not dependent upon ICAM-1 following acute LCMV infection, but this adhesion molecule does influence the size and functional quality of the memory populations that form. We also tested whether the altered functional properties of virus-specific memory CD8 T cells derived from ICAM-1 −/− mice were due to changes in the sensitivity of these cells to peptide stimulation. To address this issue, we titrated the antigenic peptides and observed minimal differences in the dose-responses of ICAM-1 +/+ and ICAM-1 −/− virus-specific memory CD8 T cells (Fig. S1 ), indicating that functional avidity of the memory populations is not regulated by ICAM-1. +/+ and ICAM-1 −/− were generally similar, as assessed by BrdU incorporation between days 30-37 following infection, which the exception of NP396-specific responses which showed a marginally higher proliferation rate in ICAM-1 −/− mice (Fig. S3 ). This result suggests that the primary cause of the elevated maintenance of CD8 T cells in ICAM-1 −/− mice is not due to altered homeostatic proliferation.
Because T-bet promotes effector CD8 T-cell differentiation, we determined the levels of this transcription factor in D b (GP33) (Fig. 2F ) and D b (NP396) (Fig. 2G ) virus-specific cells at 8 and 75 d postinfection. The levels of T-bet expression were similar in both ICAM-1 +/+ and ICAM-1 −/− virus-specific CD8 T cells at day 8 and, as expected, decreased by day 75 as immunological memory was established. The levels of T-bet were, however, somewhat reduced in the CD8 + CD127 lo , KLRG-1 hi subset in ICAM-1 −/− mice at day 75, which may contribute to the preservation of these cells.
Given the enhanced retention of CD127 lo , KLRG-1 hi virusspecific CD8 T cells in ICAM-1 −/− mice, we investigated whether this finding was associated with underlying virus persistence. Viral levels were below the limits of detection in the serum (<50 pfu/mL), kidneys (<438 pfu/g), liver (<360 pfu/g), and lungs (<1,000 pfu/g) when titered by plaque assays at days 8, 37, 75, 184, 204 (serum), 90 (kidney), and 100-151 (kidney, liver, lung) following infection. In addition, transfer of splenocytes from mice which had been infected with LCMV 30 d previously failed to prime a virus-specific CD8 T-cell response in naïve recipient animals (Fig. S4A) . Moreover, sensor CFSE-labeled virus-specific memory CD8 T cells did not divide significantly upon transfer into ICAM-1 +/+ or ICAM-1 −/− mice that had been infected with LCMV >138 d previously (Fig. S4B) , despite the signature elevation of endogenous CD127 lo , KLRG1 hi virus-specific CD8 T cells apparent in the ICAM-1 −/− recipient mice (Fig. S4C ). Collectively these findings indicate that the altered phenotypic and functional profiles of virus-specific CD8 T cells in ICAM-1 −/− mice is unlikely to be due to viral persistence.
ICAM-1 Expression on Non-T-Cell Populations Tunes the Memory
T-Cell Pool. The enhanced retention of effector-like CD8 T cells could be due to the loss of ICAM-1 expression on APCs, leading to reduced contact with these cells, or the inability to induce asymmetric division during priming, thereby resulting in a failure to properly program contraction (3, 4) . Alternatively, ICAM-1 expression on T cells may permit the activated cells to cluster and receive paracrine IL-2 signals (8), which may push the terminal differentiation of CD8 T cells that cannot subsequently be stably maintained (10, 11) . To determine whether ICAM-1 expression on T cells altered the formation of the memory T-cell pool, chimeras were generated by reconstituting Rag1 , whereas the majority of other cell types, including APC populations, express ICAM-1. Control chimeras were generated, in which all cells expressed ICAM-1, by reconstituting recipients with an 80:20 mixture of TCRβ/δ −/− and ICAM-1 +/+ bone marrow. Following infection with LCMV, no differences were detected in the fraction of virus-specific CD127 hi , KLRG1 lo and CD127 lo , KLRG1 hi CD8 T cells present in the two groups of chimeras (Fig. 3 A and B) . Thus, the loss of ICAM-1 expression on T cells has no discernable impact on attrition of CD127 lo , KLRG1
hi CD8 T cells during the memory phase of the response following LCMV infection.
We next investigated whether ICAM-1 deficiency on non-T-cell subsets regulated the formation of memory CD8 T cells and the loss of CD127 lo , KLRG1 hi CD8 T cells. To address this question, we used CD2-ICAM-1/ICAM-1 −/− transgenic mice. In these mice, the endogenous ICAM-1 genes are deleted (ICAM-1
−/−
) and murine ICAM-1 expression is exclusively driven by the human CD2 promoter (18) . This transgene causes marked ICAM-1 expression on T, B, and natural killer (NK) cells, but no detectable expression on CD11b + or CD11c + cells (Fig. 3C) . proportion of effector-like T cells in these mice (Fig. 3D) . Thus, ICAM-1 expression on nonlymphocyte populations, but not on T cells, influences the attrition of effector-like, CD127 lo , KLRG-1 hi cells following LCMV infection. Because ICAM-1 expression on nonlymphocytes had longterm consequences on the configuration of the memory pool, we investigated whether ICAM-1 deficiency was associated with abnormalities in the inception of the primary response. The recruitment, activation, and proliferation of CFSE-labeled naïve donor ICAM-1 +/+ P14 TCR transgenic CD8 T cells was evaluated 2 and 3 d following LCMV infection of ICAM-1 +/+ and ICAM-1 −/− recipient mice. The CFSE profiles revealed that the tempo of recruitment is slower in ICAM-1 −/− mice, as the fraction of donor cells recruited to respond (Fig. S5A), their division (Fig. S5B) , and their proliferation (Fig. S5C) indices are somewhat lower. Nevertheless, once the T cells do respond, they up-regulate CD25, CD43 (1B11), and T-bet, and undergo proliferation (Fig. S5D) . 
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+ recipients. These recipients were challenged with recombinant L. monocytogenes expressing the overlapping LCMV GP33 and GP34 epitopes (rLM-GP33), and responses were analyzed 6 d later. The ICAM-1 +/+ memory cells dominated the secondary response, whereas the expansion of ICAM-1 −/− donor cells was markedly depressed (Fig. 4 D and E (Fig. 4G) . Collectively, these results are particularly intriguing, because they show that even populations that phenotypically resemble bona fide memory cells are compromised if ICAM-1 expression is ablated.
We further examined the secondary proliferative responses of ICAM-1 +/+ and ICAM-1 −/− memory CD8 T cells by labeling the donor cells with CFSE before transfer (Fig. S6A) . Although ICAM-1 −/− D b (GP33)-specific CD8 T cells did proliferate and Mean values ± SD are shown from four separate experiments analyzing a total of 10-18 recipient mice per group. *P ≤ 0.01; **P ≤ 0.001; ***P ≤ 0.0001.
dilute CFSE, (Fig. S6B) these cells failed to accumulate during the secondary response (Fig. S6 C and D) . A remarkably similar outcome-of memory CD8 T cells responding, proliferating, but failing to accumulate-has also been documented for CD8 T cells lacking the high-affinity IL-2R, CD25 (20, 21) . Because ICAM-1 mediates T-cell clustering following infection and facilities the directional secretion of IL-2, we evaluated the recall responses of ICAM-1 +/+ and ICAM-1 −/− CD8 T cells derived from the bone marrow chimeras described in Fig. 3 . To determine whether ICAM-1 expression on T cells is required for robust secondary responses, memory ICAM-1 +/+ and ICAM-1 −/− CD8 T cells were isolated from the two groups of chimeras and transferred into separate groups of allelically marked recipients, which were subsequently challenged with rLM-GP33 (Fig. S7A) . The ICAM-1 −/− CD8 T cells elicited weaker secondary responses (Fig. S7B) , even though there were no detectable differences in the attrition of CD127 lo , KLRG-1 hi CD8 T cells in the donor chimeras (Fig. 3A) . Collectively, these findings support a dual role for ICAM-1, because expression of this adhesion molecule by T cells potentially programs recall potential, whereas expression on nonlymphocytes regulates the composition of the memory pool and the maintenance of residual CD127 lo , KLRG-1 hi CD8 T cells, which also mount poor secondary responses.
Discussion
Previous studies have shown abortive responses and a failure to form a memory T-cell compartment in ICAM-1-deficient mice following peptide or protein immunization (3, 12) ; however, controversy remains regarding whether ICAM-1 interactions are involved in the development of CD8 T-cell memory following infection and how ICAM-1 interactions influence the T-cell response. The initial elaboration of cytotoxic CD8 T-cell responses and the migration of virus-specific T cells into tissues has been shown to be unperturbed following LCMV infection of either ICAM-1-deficient or LFA-1-deficient animals (5, (22) (23) (24) . Following LCMV-Arm infection of ICAM-1 −/− animals, we observed equal or greater numbers of IL-2 + , CD127 hi , KLRG-1 lo virus-specific CD8 T cells, demonstrating that memory phenotype T cells can form and be maintained independently of ICAM-1 expression. Nevertheless, the recall responses of these memory phenotype cells are defective, a property that is particularly apparent upon adoptive transfer. In addition, although down-regulation of the virus-specific CD8 T-cell response proceeds in the absence of ICAM-1, the subsequent slower decay of residual "effector-like", CD127 lo , KLRG-1 hi CD8 T cells, which occurs following the initial contraction phase, is curtailed if ICAM-1 expression is ablated.
Considering the failure to maintain memory T cells in ICAM-1-deficient mice following peptide immunization, but the formation of these cells following LCMV infection, we propose a model in which ICAM-1 acts to fine tune the immune response to both low and high doses of antigen, by operating to enhance weak but restrict strong responses. Our model predicts that when antigen is limited, as in the case of peptide immunization, ICAM-1 is required to augment the priming process, most likely by promoting recruitment of naïve T cells, prolonging cell-cell interactions, and facilitating cytokine signaling, permitting the differentiation of memory T-cell precursors. In the case of pathogens that provide stronger antigenic and inflammatory stimuli, such as LCMV infection, the threshold of activation required for memory differentiation is achieved independently of ICAM-1, and, in this context, ICAM-1 interactions instead serve to further drive activation of the CD8 T cells resulting in terminal differentiation of many of the responders and programming the downsizing of the effector response.
The lack of attrition of CD127 lo , KLRG-1 hi CD8 T cells during the memory phase in the absence of ICAM-1 may not be due to differences in homeostatic proliferation (Fig. S3) . Instead, their maintenance may be governed by sensitivity to IL-15 and other cytokine survival signals (25, 26 (20, 21) . This secondary proliferative defect resembles the recall responses of ICAM-1 −/− CD127 hi , KLRG-1 lo CD8 T cells. ICAM-1-LFA-1 interactions promote T-cell-T-cell interactions and the directional secretion of IL-2 (8), which can enhance the local availability of IL-2 as the activated cells aggregate, and ICAM-1 interactions with the APC promote IL-2 production by responding CD8 T cells (6) . Thus, decreases in the IL-2 signals perceived during initial activation, due to ICAM-1 deficiency on T cells, could misprogram the responding T cells, resulting in poor secondary responses. This explanation also suggests that the T-cell "decay" requirements for ICAM-1 on nonlymphocytes are distinct from the need for this molecule to imprint secondary proliferative potential. A more provocative possibility is that the lack of ICAM-1 interactions leads to inefficient separation of memory and effector cell properties as the activated cells divide. ICAM-1 expression on APCs is required for CD8 T cells to undergo asymmetric division early during the response (4), an event that has been proposed to dictate effector and memory CD8 T-cell fate and that is influenced by antigen affinity and abundance (29) .
Our data suggest that manipulation of ICAM-1 interactions during priming could potentially bolster the development and maintenance of effector-memory populations. Although this process may curtail the development of highly proliferative memory cells, the maintenance of greater numbers of effector-like T cells may provide superior protection from certain types of pathogens, such as simian immunodeficiency virus and malaria (30, 31) . Furthermore, our model predicts that, during persistent infections, ICAM-1 may enhance the antigen-driven functional exhaustion and deletion of T cells. Thus, disrupting ICAM-1 interactions may represent a unique therapeutic target for bolstering immunity in patients with chronic infections. ) mice were purchased from Jackson Laboratory. Thy1.1. P14 TCR transgenic mice were bred in house. ICAM-1 −/− C57BL/6 mice (Icam1 tm1Alb ) have been described (16, 17) . CD2-ICAM-1/ICAM-1 −/− transgenic mice were generated as follows. Briefly, a full-length mouse ICAM-1 cDNA was cloned into a human CD2 minigene vector containing both the promoter and locus control region (18) . Following excision of the plasmid sequences, the construct was then injected into fertilized eggs obtained from matings of inbred C57BL/6 mice. Transgenic mice were then bred to ICAM-1 −/− mice. All mice were bred and maintained in fully accredited facilities at the University of Alabama at Birmingham. All procedures with experimental mice were approved by the University of Alabama at Birmingham Institutional Animal Care and Use Committee.
